Developmental Medicine & Child Neurology · 2007 · 17 citations · 14 references
Life SciencesNeurologyNeuroscienceHuman GeneticsNeuropsychiatryPediatric NeurologyEnzyme DeficienciesFolate DeficiencyGenetic DisordersNeurodevelopmental Disorders5-Alpha-reductase DeficiencyBiochemical Response AssessmentDurable Clinical ResponseFolate Deficiency TreatmentMetabolic LeukoencephalopathiesWhite Matter Involvement
Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency may present with variable neurological manifestations. Radiological features include white matter changes (leukoencephalopathy). Clinical, biochemical, and radiological response to treatment may again be variable. Here we present a 12-year follow-up of two siblings on the same treatment regimen, with contrasting long-term findings. The first patient, a female presenting at 15 years, showed a good clinical response, substantial intellectual gain, and complete reversal of leukoencephalopathy. Her brother presented at 13 years 9 months and showed limited clinical and cognitive improvement with persistence of the leukoencephalopathy. Both siblings showed a partial biochemical response to treatment.
14
Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)
Philippe Goyette, Aditya Pai, Renate Milos et al. · Mammalian Genome · 1998 · 361 citations
Mary J. Levitt, Peter F. Nixon, Jonathan H. Pincus et al. · Journal of Clinical Investigation · 1971 · 107 citations · Full text